Fineline Cube

Follow:
14778 Articles
Flare Therapeutics and Roche Enter Strategic Collaboration for Oncology Drug Discovery
CompanyDeals

Flare Therapeutics and Roche Enter Strategic Collaboration for Oncology Drug Discovery

Schrödinger and Novartis Ink Deal to Accelerate Drug Discovery Candidates
CompanyDeals

Schrödinger and Novartis Ink Deal to Accelerate Drug Discovery Candidates

CSPC Pharmaceutical Gains NMPA Approval for Clinical Trial of mRNA Vaccine SYS6026
CompanyDrug

CSPC Pharmaceutical Gains NMPA Approval for Clinical Trial of mRNA Vaccine SYS6026

NHSA and MoF Announce Medical Insurance Fund Prepayment Initiative to Aid Healthcare Institutions
Policy / Regulatory

NHSA and MoF Announce Medical Insurance Fund Prepayment Initiative to Aid Healthcare Institutions

Fineline Info & Tech (Flcube.com) provides you with comprehensive information about InnoCare Pharma, including details on the company, its pharmaceuticals, policies, deals, healthcare enterprises, research and development, hospitals, legal patents, and internet healthcare. More information about InnoCare Pharma please access Flcube.com
Company

InnoCare Pharma Reports 29.8% Revenue Increase in Q3 2024 Financials

Fineline Info & Tech (Flcube.com) provides you with comprehensive information about Evotec, including details on the company, its pharmaceuticals, policies, deals, healthcare enterprises, research and development, hospitals, legal patents, and internet healthcare. More information about Evotec please access Flcube.com
CompanyDeals

Triton Partners Mulls Acquisition of Germany’s Evotec SE, Shares Soar 22%

GenScript Biotech Expands in Australia with New Sydney Operations and Logistics Center
Company

GenScript Biotech Expands in Australia with New Sydney Operations and Logistics Center

Leman Biotech Secures Over USD 13.9 Million in Series A Financing for Next-Gen Cancer Immunotherapies
CompanyDeals

Leman Biotech Secures Over USD 13.9 Million in Series A Financing for Next-Gen Cancer Immunotherapies

Biocytogen's First-in-Class B7H3/PTK7 Bispecific ADC Option Exercised by IDEAYA Biosciences
CompanyDeals

Biocytogen’s First-in-Class B7H3/PTK7 Bispecific ADC Option Exercised by IDEAYA Biosciences

Gan & Lee's GZR18 Shows Significant Weight Loss in Phase IIb Study at ObesityWeek 2024
CompanyDrug

Gan & Lee’s GZR18 Shows Significant Weight Loss in Phase IIb Study at ObesityWeek 2024

J&J's Nipocalimab Receives FDA Breakthrough Therapy Designation for Sjögren's Disease
CompanyDrug

J&J’s Nipocalimab Receives FDA Breakthrough Therapy Designation for Sjögren’s Disease

Zai Lab and argenx Receive NMPA Approval for Vygart Hytrulo in Chronic Inflammatory Demyelinating Polyneuropathy
CompanyDrug

Zai Lab and argenx Receive NMPA Approval for Vygart Hytrulo in Chronic Inflammatory Demyelinating Polyneuropathy